Nestle India's net rose 8.27 per cent to Rs 4,583.63 crore during the period under review. It was at Rs 4,233.27 crore in the corresponding period of last fiscalpress
The October-December quarter included some key festivals that typically spur demand. Most Indian lenders have reported double-digit loan growth for the period
The company had posted a consolidated net profit of Rs 154.81 crore a year ago, Trent Ltd said in a regulatory filing
The company's total expenses rose to Rs 456.01 crore during the quarter under review, from Rs 415.99 crore a year ago
The company had reported a Profit After Tax (PAT) of Rs 77 crore in the October-December period of the last fiscal
In a statement, the PSU said that NLCIL incorporated a new wholly-owned subsidiary NLC India Green Energy Ltd (NIGEL) to undertake green projects
The company posted a net profit of Rs 97.4 crore during the October-December quarter a year ago, according to a regulatory filing
Berger Paints on Tuesday posted a 49 per cent year-on-year increase in its consolidated net profit to Rs 300.16 crore for the third quarter of the current financial year.
The company had posted a consolidated net profit of Rs 61.22 crore in the October-December quarter a year ago, Radico Khaitan said in a BSE filing
He also highlighted that the company's international business performed extremely well with robust double-digit growth across key markets
On a sequential basis, the company exhibited a 5.39 per cent decline in revenue along with PAT, which also declined by 8.79 per cent. The EBITDA grew by 61 per cent year-on-year, reaching Rs 563 crore
The revenue from operations in the third quarter of the current fiscal rose 49 per cent to Rs 89.23 crore from Rs 68.8 crore in the same period a year ago
The company reported a loss after tax of Rs 13.59 crore ($1.64 million) in the quarter ended Dec. 31, compared to a profit after tax of Rs15.78 crore a year ago
The company closed a Qualified Institutional Placement (QIP) in December 2023, raising Rs 403 crore that provides the necessary fuel for ambitious growth plans, including setting up of a foundry
Total income stood at Rs 588.4 crore in the third quarter of this fiscal, according to a regulatory filing
The company's consolidated revenue from operations grew 22 per cent YoY to Rs 1,789 crore, up from Rs 1,462 crore a year ago and Rs 1,507 crore in Q2 FY24
The weak earnings come in face of intense price competition. The company has previously mentioned reducing certain product prices after competitors took advantage of declining raw material expenses
Revenue increased to Rs 845 crore in the third quarter compared to Rs 793 crore in the year-ago period, JB Pharma said in a statement
Revenue on a consolidated basis stood at Rs 2,328.31 crore in Q3FY24, up by 14.7 per cent from Rs 2,024 crore in the year-ago period
The company's consolidated net profit rose 97% to 161.9 million rupees ($1.95 million) in the third quarter ended Dec. 31. It had posted a drop in net profit in three of its previous five quarters